Strong results seen for combination hypertensive drugs in March
Sales of Novartis’s Exforge (amlodipine plus valsartan) rose 19.7 percent to 5.9 billion won in March, compared to the same period last year.
Astra Zeneca’s Atacand (candesart...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
